💨 Abstract

VJ Group has launched VJ Bio, a biotech company focused on creating an ecosystem to develop affordable and effective next-generation therapies. The company aims to focus on five key pillars: end-to-end supply chain, manufacturing, delivery vehicles, genetic payloads, and analytics. VJ Bio's initial step is plasmid DNA manufacturing services, with plans to expand capabilities at a new state-of-the-art facility near Bangalore International Airport.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖